CHAPTER IX BIBILOGRAPHY

1. gamal a. mohamed a, sabrin r.m. ibrahim b,*, ehab s. elkhayat a, riham salah el dine c,
et al. natural anti-obesity agents, bulletin of faculty of pharmacy, cairo university
(2014) 52, 269284.
2. iram nazish*, s h ansari, poonam arora, adil ahmad, et al. antiobesity activity of
zingiber officinale.
3. Ram Kumar sahu1, Deepak prashar, et al. current treatment strategies for obesity
including indian scenario.
4. mrs.supriya.k m.pharm, et al. anti-obesity activity of shorea robusta geartn. leaves
extracts in albino rats. department of pharmacology
5. John c. Clapham, jonathan r.s. arch, et al. targeting thermogenesis and related
pathways in anti-obesity drug discovery.
6. hamdy o, uwaifo gi, oral ea, et al. obesity. Drugs & diseases 2015.
7. jang ws, choung sy, et al. antiobesity effects of the ethanol extract of laminaria
japonica areshoung in high-fat-diet-induced obese rat.
8. costa jv, duarte js, et al. adipose tissue and adipokines. 2006; 19: 251-6.
9. shaik rahiman*, tarek h el-metwally and divya shrivastava, et al. adipose tissue: a
regulator for obesity and its complications.
10. grube b, chong wf, chong pw, riede, et al. weight reduction and maintenance with iqp-
pv-101: a 12-week randomized controlled study with a 24-week open label period.
obesity (silver spring). 2014;22(3):645-651.
11. marisa coelho, teresa oliveira, ruben fernandes, et al. biochemistry of adipose tissue:
an endocrine organ.
12. homayoun l. daneschvar, md, mark d. aronson, md, gerald w. smetana, et al. fda
approved anti-obesity drugs in the united states.
13. alkilany salem abuzaid*,elin yulinah sukandar, neng fisheri kurniati, i ketut adnyana,
et al. preventive effect on obesity of mangosteen (garcinia mangostana l.) pericarp
ethanolic extract by reduction of fatty acid synthase level in monosodium glutamate
and high-calorie diet-induced male wistar rats.
14. Zaghi, D Maibach (2007). "Survey of Safety and efficacy information in drug inserts
for topical prescription medications". American Journal of Clinical Dermatology 8
(1): 4346.
15. Gareth Williams, Gema Fruhbeck, et al. Obesity: Science to Practice , pg 80-85.

School of Pharmaceutical Sciences & Technologies, JNTUK Page 105

 CHAPTER IX BIBILOGRAPHY

16. Stuart P. Weisberg,1 Daniel McCann,1 Manisha Desai,2 Michael Rosenbaum,

Rudolph L. Leibel, and Anthony W. Ferrante, Jr , et al. Obesity is associated with
macrophage accumulation in adipose tissue, 17961808 (2003).
17. Samuel Klein, MD, et al. Is Visceral Fat Responsible for the Metabolic Abnormalities
Associated With Obesity? ,2010 Jul; 33(7): 16931694.
18. Olga T. Hardya,b, Michael P. Czecha, and Silvia Corveraa, et al. What causes the
insulin resistance underlying obesity?
19. Gareth Williams, Gema Fruhbeck, et al. Obesity: Science to Practice
20. Marisa Coelho1,2, Teresa Oliveira2, Ruben Fernandes, et al. Biochemistry of adipose
tissue: an endocrine organ
21. Debasis Bagchi Harry G. Et al. Preuss Obesity Epidemiology, Pathophysiology,and
Prevention)
22. 22. Gamal A. Mohamed a, Sabrin R.M. Ibrahim b,*, Ehab S. Elkhayat a,
Riham Salah El Dine Natural anti-obesity agents (2014) 52, 269284.
23. 23. Jebb SA. Aetiology of Obesity. In: Finer N, Editor. Obesity. Vol. 53(2). London:
British Medical Bulletin, Royal society of medicine press limited; 1997.
24. John P H Wilding*et al., Pathophysiology and aetiology of obesity ,Obesity and
metabolic complications, January 2011Volume 39, Issue 1, Pages 610.
25. Timar, R.O., 1999.In:Serban,V.,BabesP.A.,editors. Clinica Medicala. Teoriesipractica
,Editurade Vest , Timisoara ; pp . 83 - 198 .
26. Aronne ,L.J., 2002 .Classfication of obesity and assessment of obesity- related health
risks. Obes. Res. 10, S105-S115 .
27. Richard L. Atkinson*, Etiologies of Obesity, The Management of Eating Disorders
and Obesity, Part of the series Nutrition and Health pp 105-118.
28. Arya SN, Kumar R. Obesity: Review article. J Indian Acad Clin Med 2004; 5(2): 166-
81.
29. Collantes R, Ong JP, Younossi ZM. Non-alcoholic fatty liver disease and the
epidemic of obesity. Cleveland Clin J Med 2004; 71(8): 657-64.
30. mr. v. maruthappan antiobesity and hypolipidemic effects of proprietary herbal drugs
geriforte and haritaki in male albino rats fed high fat diet
31. Natural anti-obesity agents Gamal A. Mohamed a, Sabrin R.M. Ibrahim b,*, Ehab S.
Elkhayat a, Riham Salah El Dine , (2014) 52, 269284.
32. Aronne, louis j.; Classification of obesity and assessment of obesity-related health
risks. Obes res. 2002; 10:105s115s

School of Pharmaceutical Sciences & Technologies, JNTUK Page 106

 CHAPTER IX BIBILOGRAPHY

33. Junghyo Jo*, Oksana Gavrilova, Stephanie Pack, William Jou, Shawn Mullen, Anne E.
Sumner,Samuel W. Cushman, Vipul Periwa*et al. (2009) Hypertrophy and/or
Hyperplasia: Dynamics of Adipose Tissue Growth. PLoS Comput Biol 5(3), March
2009, Volume 5, Issue 3, e1000324.
34. Aronne, Louis* j. Classification of obesity and assessment of obesity-related health
risks. Obes Res. 2002; 10:105S115S.
35. Chidrawar, Vijay R., 2011, Pharmacological and phytochemical studies of ayuvedic
plants for anti-obesity and anti-diabetic activity.
36. Obesity: Preventing and managing the global epidemic. WHO Technical Report
Series 894, Report of a WHO consultation. Geneva: World Health Organization;
1998.
37. Rezaee F, Dashty M (2013) Role of Adipose Tissue in Metabolic System Disorders
Adipose Tissue is the Initiator of Metabolic Diseases. J Diabetes Metab Metab, 2013,
S13ISSN: 2155-6156 JDM.
38. Kevin D. Hall,4 Steven B. Heymsfield Energy balance and its components:
implications for body weight regulation.
39. Hall KD*, Heymsfield SB, Kemnitz JW, Klein S, Schoeller DA, Speakman JR.
Energy balance and its components: implications for body weight regulation. Am J
Clin Nutr 2012; 95: 98994.
40. Thaman R.G*, Arora G. P., Pathophysiology the discussion goes on, J. Phys. Pharm.
Adv., 2013, 3(3):48-56.
41. BRENT E. WISSE, The Inflammatory Syndrome: the role of adipose tissue cytokines
in metabolic disorders linked to obesity, J Am Soc Nephrol 15: 27922800, 2004.
42. Kumar et al. Leptin: Pathogenesis and Treatment of Morbid Obesity; Current
Gastroenterology Reports 2000, 2:337344; Current Science Inc. ISSN 15228037
43. Andrew S Greenberg and Martin S Obin Obesity and the role of adipose tissue in
inflammation and metabolism, Am J Clin Nutr 2006; 83(suppl):461S5S.
44. Fitzgerald PA, Tierney LM, Mcphee SJ et al. Common presentations in
endocrinology; obesity - Current Medical Diagnosis and Treatment. New Delhi:
Lange Medical Books; 2003.
45. Bray GA. Strategies for discovering drugs to treat obesity. In: Kopelman PG, Stock
MJ, Editors. Clinical Obesity. Oxford: Blackwell Science; 1998.

School of Pharmaceutical Sciences & Technologies, JNTUK Page 107

 CHAPTER IX BIBILOGRAPHY

46. Wilding J, Widdowson P, Williams G. Neurobiology. In: Finer N, Editor. Obesity.

Vol. 53(2). London: British Medical Bulletin, Royal society of Medicine Press Ltd;
1997.
47. Physiological regulation of energy balance A review of the literature SW van den
Berg, EJM Feskens, B Hoebee,
48. Jaswinder K. Sethi and Antonio J. Vidal-Puig , Adipose Tissue Development,
Structure and Function.
49. Rezende FA, Rosado LE, Ribeiro RC, Vidigal FC, Vasques AC, Bonard IS, Carvalho
CR. Body mass index and waist circumference: association with cardiovascular risk
factors. Arq Bras Cardiol 2006; 87(6): 728-34.
50. Cinti S, Mitchell G, Barbatelli G et al. Adipocyte death defines macrophage
localization and function in adipose tissue of obese mice and humans. J Lipid Res
2005; 46: 2347-55
51. Wolfram S, Wang Y, Thielecke F. Anti-obesity Effects of Green Tea: From Bedside
to Bench. Mol Nutr Food Res 2006; 50: 176-87.
52. Bays H, Blonde L, Rosenson R. Adiposopathy: how do diet, exercise and weight loss
drug therapies improve metabolic disease in overweight patients? Expert Rev
Cardiovasc Ther 2006; 4(6): 871-95.
53. Kirsi H Pietilinen*,Jaakko Kaprio, Patrik Borg, Guy Plasqui, Hannele Yki-Jrvinen,
Urho M. Kujala, Richard J Rose, Klaas R Westerterp,and Aila Rissanen et al.,Physical
inactivity and obesity: A vicious circle, Obesity (Silver Spring). 2008 February ;
16(2): 409414.
54. Nick H. T. ten Hacken "Physical Inactivity and Obesity", Proceedings of the
American Thoracic Society, Vol. 6, No. 8 (2009), pp. 663-667.
55. Adipose Tissue: A Regulator for Obesity and Its Complications Shaik Rahiman1,2*,
Tarek H El-Metwally.
56. Hafeezullah, Aslam M. Leptin: fights against obesity. Pak J Physiol 2006; 2(1): 1-7.
57. Pajvani UP, Du X, Combs TP. Structure-function studies of the adipocyte secreted
hormone - Acrp30/adiponectin. J Biol Chem 2003; 278: 9073-85.
58. Qi Y, Takahashi N, Hileman SM et al. Adiponectin acts in the brain to decrease body
weight. Nat Med 2004; 10: 524-29.
59. Ouchi N, Shibata R, Walsh K. Cardioprotection by adiponectin. Trends Cardiovasc
Med 2006; 16:141-46.

School of Pharmaceutical Sciences & Technologies, JNTUK Page 108

 CHAPTER IX BIBILOGRAPHY

60. Nagoya J. Med. Sci. 74. 19 ~ 30, 2012 , adipocytokines and obesity-linked disorders
noriyuki ouchi1 , koji ohashi1 , rei shibata2 and toyoaki murohara2
61. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose tissue expression of tumor
necrosis factor: direct role in obesity linked insulin resistance. Science 1993; 259: 87-
90.
62. York, D,A., 1996. Lessons from animal models of obesity. Endocrinol. Metab. Clin.
North Am. 25(4), 781-800.
63. Prunet-Marcassus, B., Desbazeille, M., Bros, A., Louhce, K., Delagrange, P., Renard,
2003. Melatonin reduces body weight gain in Sprague Dawlay rats with diet induced
obesity. Endocrinology 144, 5347-5352.
64. Shimizu, Y., Yamazaki, M., Nakanish, K., Sakurai, M., Sanada, A., Takewaki, 2003,
Enhanced responses of the chorda tympani nerve to sugars in the ventromedial
hypothalamic obese rat. J. Neurophysiol. 90, 128-33
65. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes.
Nature 2001; 409: 307-12.
66. Trujillo ME, Sullivan S, Harten I et al. Interleukin-6 regulates human adipose tissue
lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab 2004; 89:
5577-82.
67. Metabolic syndrome pathophysiology: The role of adipose tissue , Martin Laclaustra,
(2007) 17, 125-139.
68. Kulkarni SK, Kaur G. Obesity: An insight into its neurochemical basis and treatment.
Indian J Pharmacol 1999; 31: 388-403.
69. Munro JF, Patrick AW. The Management of Obesity. Medicine International 1994;
22(10): 389-92.
70. Laquatra I. Nutrition for weight management. Food Nutrition and Diet Therapy.
Philadelphia: WB Saunders Co.; 2000.
71. MINgMINg gAo ANd dexI Liu Gene Therapy for Obesity: Progress and Prospects
72. Nick F, Editor. Present and future pharmacological approaches. Chapter 10 in
Obesity, Vol. 53(2). London: British Medical Bulletin, Royal Society of Medicine
Press Ltd.; 1997.
73. Kulkarni SK, Kaur G. Obesity: An insight into its neurochemical basis and treatment.
Indian J Pharmacol 1999; 31: 388-403.
74. Current Treatment Strategies for Obesity Including Indian scenario, Ram Kumar
Sahu1, Deepak Prashar2

School of Pharmaceutical Sciences & Technologies, JNTUK Page 109

 CHAPTER IX BIBILOGRAPHY

75. Current Treatment Strategies for Obesity Including Indian scenario, Ram Kumar
Sahu1, Deepak Prashar
76. Harris RB. The impact of high- or low fat cafeteria foods on nutrient intake and
growth of rats consuming a diet containing 30% energy as fat. Int J Obes 1993;
17: 307-15.
77. Sclafani A, Springer D. Dietary obesity in adult rat: similarities to
hypothalamic and human obesities. Physiol Behav 1976; 17: 461-71.
78. Vogel HG, Vogel WH. Drug discovery and evaluation, pharmacological assay.
New York: Berlin Heidelberg, Springer-Verlag; 1997.
79. Morris MJ, Tortelli CF, Filippis A, Proietto J. Reduced BAT function as a
mechanism for obesity in the hypophagic, neuropeptide Y deficient
monosodium glutamate-treated rat. Regul Pept 1998; 75-76:441-47.
80. Bitter orange , Wikipedia
81. Pharmacognosy by kokate
82. Determination of adrenergic agonists from extracts and herbal products of Citrus
aurantium L. var. amara by LC_ Federica Pellati a, Stefania Benvenuti a,*, Michele
Melegari a, Fabio Firenzuoli b)
83. Citrus aurantium, an ingredient of dietary supplements marketed for weight loss:
current status of clinical and basic research. Fugh-Berman A1, Myers A.)
84. 3 ([Standardization of the sour orange flower and leaf]. [Article in French] Carnat
A1, Carnat AP, Fraisse D, Lamaison JL
85. The Safety of Citrus aurantium (Bitter Orange) and its Primary Protoalkaloid
pSynephrine, Sidney J. Stohs,1* Harry G. Preuss2 and Mohd Shara3, 2011)
86. Google
87. (treatment of obesity: an herbal approach Amanpreet Kaur, Deepanshu Aggarwal,
Amit Goyal*, Anjoo Kamboj, Upendra K. Jain)
88. Green coffee beans, Wikipedia
89. .Beynen,A.C.,denEngelsman,G.,Scholz,K.E.,West,C.E.,1983.Casein-induced
hypercholesterolemia in rabbits: distribution of cholesterol,triglycerides and
phospholipids between serum and liver.Ann.Nutr.Metab.27(2),117-124.
90. Elshorbagy,A.K.,Valdivia-Garcia,M.,Refsum,H.,Butte,N.,2012.The Association of
Cysteine with Obesity, Inflammatory Cytokines and Insulin Resistance in Hispanic
Children and Adolescents.PLoSONE.7(9),e44166.

School of Pharmaceutical Sciences & Technologies, JNTUK Page 110

 CHAPTER IX BIBILOGRAPHY

91. Brown lee, M.A., 2003. A radical explanation for glucose-induced beta cell
dysfunction. J.Clin.Invest.112, 1788-1790.
92. .Cao,D.,Lu,H.,Lewis,T.L.,Li,L.,2007.In take of Sucrose-sweetened Water Induces
Insulin Resistance and Exacerbates Memory Deficits and Amyloidosis in a
Transgenic Mouse Model of Alzheimer Disease.J.Biol.Chem.282(50),36275-36282 .
157.Haught,D.,Koepke,M.,GoldberHeavilin,L.,Griffin,A.,Cunha,T.,2003.The
Essentials of Custom Diets for Laboratory Animals.http://www.test diet.com/
93. .Kritchevsky,D.,Tepper,S.A.,Vessel inovitch,D.,Wissler,R.W.,1973.Cholesterol
Vehicle in experimental atherosclerosis Part 13.Randomized peanut oil.
Atherosclerosis. 17(2), 225-243.
94. . Matsuo,T.,Take uchi,H., Suzuki,H., Suzuki,M.,2002. Body fat accumulation is
greater in rats fed a beef tallow diet than in rats fed a safflower or soyabean oil
diet.Asia Pac.J.Clin.Nutr.11(4):302-308.
95. Reeves,P.G., Nielsen,F.H., Fahey,G.C.,1993.AIN-93 purified diet for laboratory
rodents: final reports of the American Institute of Nutrition ad hoc writing committee
on the reformation of the AIN-76 A rodent diet.J.Nutr.123,1939-1951.
96. Antiobesity Effect of Citrus Aurantium (Bitter Orange) on Wistar Albino Rat Fed
with Formulated Fatty Diet , Sule, J.O. ,Vol. 2 (6), pp. 104-108, June, 2016

97. 97. 147 152, 2009, Anti-Obesity and Hypotriglyceridemic Properties of Coffee
Bean Extract in SD Rats, Kazunari Tanaka1*, Shoko Nishizono
98. Green coffee bean extract improves obesity by decreasing body fat in high-fat diet-
induced obese mice, Bong-Keun Choi1, 2016; 9(7): 635643
99. Studies on Bitter Orange Peel Extract as an Anti-Obesity Agent. ,C.I. Igwilo, Ph.D.1;
A.S. Fatoke
100. www.google.co.in
101. Preliminary Phytochemical Investigations with Quantitative Fractionation of Orange
Pulp (Citrus Aurantium Var. Dulcis L.):Natural Product Waste as Medicine By Rufai
Y & Fatimah S
102. Coffee Constituents, Adriana Farah

School of Pharmaceutical Sciences & Technologies, JNTUK Page 111